NanoLogix, Inc. (NNLX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
+0.000099 (9,900.00%)
At close: Jun 9, 2026
NanoLogix Market Cap
NanoLogix has a market cap or net worth of $16.29 thousand as of June 26, 2026. Its market cap has decreased by -99.60% in one year.
Market Cap
16.29K
Enterprise Value
n/a
Revenue
1.27K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 18, 2003, NanoLogix's market cap has decreased from 696.05K to 16.29K, a decrease of -97.66%. That is a compound annual growth rate of -15.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 16.29K | 9,893.25% |
| Dec 27, 2023 | 163.00 | -99.00% |
| Dec 29, 2022 | 16.29K | 9,893.25% |
| Dec 30, 2021 | 163.00 | -100.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scopus BioPharma | 25.25K |
| Panbela Therapeutics | 24.27K |
| Aridis Pharmaceuticals | 21.33K |
| Health Sciences Group | 20.51K |
| Regenicin | 15.35K |
| Virpax Pharmaceuticals | 13.79K |
| ObsEva | 11.72K |
| Biostax | 10.77K |